BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 9372883)

  • 21. [The usefulness of autologous blood transfusion for urologic surgery].
    Maegawa M; Usida H; Maekawa S; Inoue K; Kaneko Y; Ohmori K; Nishimura K
    Hinyokika Kiyo; 2001 Sep; 47(9):625-8. PubMed ID: 11692598
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Baseline hemoglobin as a predictor of risk of transfusion and response to Epoetin alfa in orthopedic surgery patients.
    de Andrade JR; Jove M; Landon G; Frei D; Guilfoyle M; Young DC
    Am J Orthop (Belle Mead NJ); 1996 Aug; 25(8):533-42. PubMed ID: 8871751
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anemia in the critically ill.
    Shander A
    Crit Care Clin; 2004 Apr; 20(2):159-78. PubMed ID: 15135458
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autologous blood donation and epoetin alfa in cancer surgery.
    Jeekel J
    Semin Hematol; 1996 Apr; 33(2 Suppl 2):43-6; discussion 47. PubMed ID: 8723582
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Utilization of autologous blood donation during radical retropubic prostatectomy.
    Das A; Strup S; Canfield S; Mulholland SG; Gomella LG
    Tech Urol; 1998 Sep; 4(3):131-5. PubMed ID: 9800890
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epoetin alfa. A bloodless approach for the treatment of perioperative anemia.
    Faris PM; Ritter MA
    Clin Orthop Relat Res; 1998 Dec; (357):60-7. PubMed ID: 9917701
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elective coronary and valve surgery without blood transfusion in patients treated with recombinant human erythropoietin (epoetin-alpha).
    PodestĂ  A; Carmagnini E; Parodi E; Dottori V; Crivellari R; Barberis L; Audo A; Lijoi A; Passerone G
    Minerva Cardioangiol; 2000 Nov; 48(11):341-7. PubMed ID: 11214425
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics and pharmacodynamics of epoetin delta in two studies in healthy volunteers and two studies in patients with chronic kidney disease.
    Smith WB; Dowell JA; Pratt RD
    Clin Ther; 2007 Jul; 29(7):1368-80. PubMed ID: 17825688
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of perioperative blood transfusion on prostate cancer recurrence.
    Ford BS; Sharma S; Rezaishiraz H; Huben RS; Mohler JL
    Urol Oncol; 2008; 26(4):364-7. PubMed ID: 18367097
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of preoperative erythropoietin administration in pediatric neuromuscular scoliosis patients.
    Vitale MG; Privitera DM; Matsumoto H; Gomez JA; Waters LM; Hyman JE; Roye DP
    Spine (Phila Pa 1976); 2007 Nov; 32(24):2662-7. PubMed ID: 18007241
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epoetin alfa as an adjuvant to autologous blood donation.
    Beris P
    Semin Hematol; 1996 Apr; 33(2 Suppl 2):27-9; discussion 30. PubMed ID: 8723578
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epoetin alfa as an adjunct to autologous blood donation in patients with a low hematocrit scheduled for elective orthopedic surgery.
    Adamson J
    Semin Hematol; 1996 Apr; 33(2 Suppl 2):15-6; discussion 17. PubMed ID: 8723575
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autologous blood donation plus epoetin alfa in nonanemic orthopedic surgery patients.
    Baudoux E
    Semin Hematol; 1996 Apr; 33(2 Suppl 2):31-2; discussion 33. PubMed ID: 8723579
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autologous versus allogeneic transfusion: patients' perceptions and experiences.
    Graham ID; Fergusson D; Dokainish H; Biggs J; McAuley L; Laupacis A
    CMAJ; 1999 Apr; 160(7):989-95. PubMed ID: 10207337
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced efficacy of autologous blood donation with epoetin alfa.
    Nydegger U
    Semin Hematol; 1996 Apr; 33(2 Suppl 2):39-40; discussion 41-2. PubMed ID: 8723581
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Usefulness of recombinant human erythropoietin on predeposit autologous blood transfusion in patients undergoing radical prostatectomy].
    Hashine K; Karashima T; Kasahara K; Sumiyoshi Y
    Hinyokika Kiyo; 1997 Jun; 43(6):411-4. PubMed ID: 9250490
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An open-label, randomized study to compare the safety and efficacy of perioperative epoetin alfa with preoperative autologous blood donation in total joint arthroplasty.
    Stowell CP; Chandler H; Jové M; Guilfoyle M; Wacholtz MC
    Orthopedics; 1999 Jan; 22(1 Suppl):s105-12. PubMed ID: 9927110
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improving the efficacy of preoperative autologous blood donation in patients with low hematocrit: a randomized, double-blind, controlled trial of recombinant human erythropoietin.
    Price TH; Goodnough LT; Vogler WR; Sacher RA; Hellman RM; Johnston MF; Bolgiano DC; Abels RI
    Am J Med; 1996 Aug; 101(2A):22S-27S. PubMed ID: 8928704
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics and pharmacodynamics of once-weekly subcutaneous epoetin alfa in critically ill patients: results of a randomized, double-blind, placebo-controlled trial.
    Vincent JL; Spapen HD; Creteur J; Piagnerelli M; Hubloue I; Diltoer M; Roman A; Stevens E; Vercammen E; Beaver JS
    Crit Care Med; 2006 Jun; 34(6):1661-7. PubMed ID: 16607233
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subcutaneous epoetin alfa as an adjunct to autologous blood donation before elective coronary artery bypass graft surgery.
    Gombotz H
    Semin Hematol; 1996 Apr; 33(2 Suppl 2):69-70; discussion 71-2. PubMed ID: 8723587
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.